We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.77B
AUM Growth
+$297M
Cap. Flow
+$195M
Cap. Flow %
11%
Top 10 Hldgs %
25.89%
Holding
186
New
46
Increased
63
Reduced
28
Closed
46

Top Buys

Rank Stock Value
1
CPAY icon
Corpay
CPAY
+$50.4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$40.6M
3
CNC icon
Centene
CNC
+$33.7M
4
CLVT icon
Clarivate
CLVT
+$27.5M
5
BAX icon
Baxter International
BAX
+$23.8M

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$35.3M
2
CRM icon
Salesforce
CRM
+$28.3M
3
FLEX icon
Flex
FLEX
+$21.2M
4
IPGP icon
IPG Photonics
IPGP
+$18.1M
5
LYFT icon
Lyft
LYFT
+$17.6M

Sector Composition

Rank Sector Weight
1 Technology 30.43%
2 Healthcare 14.56%
3 Communication Services 14.3%
4 Consumer Discretionary 11.94%
5 Industrials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGC icon
176
Superior Group of Companies
SGC
$206M
-179,855
Closed -$1.81M
SHC icon
177
Sotera Health
SHC
$5.41B
-320,388
Closed -$2.67M
SMG icon
178
ScottsMiracle-Gro
SMG
$3.63B
-85,702
Closed -$4.16M
SOFI icon
179
SoFi Technologies
SOFI
$23.4B
-673,864
Closed -$3.11M
TDS icon
180
Telephone and Data Systems
TDS
$3.88B
-421,339
Closed -$4.42M
TREE icon
181
LendingTree
TREE
$453M
-52,843
Closed -$1.13M
U icon
182
Unity
U
$19B
-237,133
Closed -$6.78M
UBER icon
183
Uber
UBER
$159B
-172,472
Closed -$4.27M
WKC icon
184
World Kinect Corp
WKC
$1.89B
-576,770
Closed -$15.8M
XLF icon
185
PUT
State Street Financial Select Sector SPDR ETF
XLF
$59B
-2,350,000
Closed -$80.4M
CVT
186
DELISTED
Cvent Holding Corp. Common Stock
CVT
-42,186
Closed -$228K

Similar funds

Invenomic Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Invenomic Capital Management held 186 positions worth $1.77B, up 20% from $1.47B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management deployed $195M of net new capital in Q1 2023, opening 46 new positions and adding to 63 existing holdings. Its largest new stake was Corpay: 248,424 shares worth $52.4M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Applovin, an estimated $35.3M trimmed.

  • Invenomic Capital Management's largest Q1 2023 buy was Corpay: 248,424 shares worth $52.4M.
  • Invenomic Capital Management added most to Centene in Q1 2023, an estimated $33.7M increase.
  • Invenomic Capital Management's biggest Q1 2023 reduction was Applovin, cutting an estimated $35.3M.
  • Invenomic Capital Management fully exited Salesforce in Q1 2023, selling an estimated $28.3M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $1.77B portfolio in Q1 2023.
  • Invenomic Capital Management opened 46 new positions and closed 46 in Q1 2023.
  • Invenomic Capital Management's portfolio value rose 20% quarter-over-quarter to $1.77B.

Based on Invenomic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.